Jacobs John C has filed 27 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 551500 shares of NOVAVAX INC ($NVAX) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Non-Statutory Stock Option NQ | 551500 | $0.00 | 551,500.0000 | 168,195,000 | 9999.99% | 0.33% |
| March 3, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Common Stock | 150167 | $0.00 | 264,130.0000 | 168,195,000 | 131.77% | 0.09% |
| March 3, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | F | Common Stock | 69288 | $9.49 | 225,680.0000 | 168,195,000 | 23.49% | 0.04% |
| March 3, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Restricted Stock Units | 150167 | $0.00 | 300,333.0000 | 168,195,000 | 33.33% | 0.09% |
| March 1, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Restricted Stock Units | 83333 | $0.00 | 0.0000 | 168,195,000 | 100.00% | 0.05% |
| March 1, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | F | Common Stock | 38450 | $10.14 | 225,680.0000 | 168,195,000 | 14.56% | 0.02% |
| March 1, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Common Stock | 83333 | $0.00 | 264,130.0000 | 168,195,000 | 46.09% | 0.05% |
| March 2, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Non-Statutory Stock Option NQ | 551500 | $9.09 | 551,500.0000 | 168,195,000 | 9999.99% | 0.33% |
| March 2, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Restricted Stock Units | 367500 | $0.00 | 367,500.0000 | 168,195,000 | 9999.99% | 0.22% |
| Jan. 23, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Restricted Stock Units | 83197 | $0.00 | 0.0000 | 168,195,000 | 100.00% | 0.05% |
| Jan. 23, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Common Stock | 83197 | $0.00 | 219,929.0000 | 168,195,000 | 60.85% | 0.05% |
| Jan. 23, 2026 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | F | Common Stock | 39132 | $9.17 | 180,797.0000 | 168,195,000 | 17.79% | 0.02% |
| March 3, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | 2025 Non-statutory Stock Option NQ | 676000 | $7.87 | 676,000.0000 | 152,190,000 | 9999.99% | 0.44% |
| March 3, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | 2025 Restricted Stock Units RSU | 450500 | $0.00 | 450,500.0000 | 152,190,000 | 9999.99% | 0.30% |
| March 1, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | F | Common Stock | 38451 | $8.33 | 136,732.0000 | 152,190,000 | 21.95% | 0.03% |
| March 1, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Restricted Stock Units | 83334 | $0.00 | 166,666.0000 | 152,190,000 | 33.33% | 0.05% |
| March 1, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Common Stock | 83334 | $0.00 | 175,183.0000 | 152,190,000 | 90.73% | 0.05% |
| Jan. 23, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | F | Common Stock | 38873 | $9.55 | 91,849.0000 | 152,190,000 | 29.74% | 0.03% |
| Jan. 23, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Restricted Stock Units | 83196 | $0.00 | 83,197.0000 | 152,190,000 | 50.00% | 0.05% |
| Jan. 23, 2025 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Common Stock | 83196 | $0.00 | 130,722.0000 | 152,190,000 | 175.05% | 0.05% |
| March 1, 2024 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 100,768,000 | 9999.99% | 0.50% |
| March 1, 2024 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Restricted Stock Units | 250000 | $0.00 | 250,000.0000 | 100,768,000 | 9999.99% | 0.25% |
| Jan. 23, 2024 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Common Stock | 83197 | $0.00 | 83,197.0000 | 100,768,000 | 9999.99% | 0.08% |
| Jan. 23, 2024 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | F | Common Stock | 40093 | $4.26 | 43,104.0000 | 100,768,000 | 48.19% | 0.04% |
| Jan. 23, 2024 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | M | Restricted Stock Units | 83197 | $0.00 | 166,393.0000 | 100,768,000 | 33.33% | 0.08% |
| Jan. 23, 2023 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Restricted Stock Units | 249590 | $0.00 | 249,590.0000 | 78,183,000 | 9999.99% | 0.32% |
| Jan. 23, 2023 | NOVAVAX INC | $NVAX | Jacobs John C | President and CEO | A | Stock Option (Right to buy) | 290700 | $0.00 | 290,700.0000 | 78,183,000 | 9999.99% | 0.37% |